Spirodecanone
| Names | |
|---|---|
| Other names
1-Phenyl-1,3,8-triazaspiro[4,5]decan-4-one
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
| EC Number |
|
| MeSH | spirodecanone |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H17N3O | |
| Molar mass | 231.299 g·mol−1 |
| Density | g/cm3 (20 °C) |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H315, H319, H335 | |
| P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Spirodecanone refers to a class of spirocyclic ketones, often studied for their potential applications in medicinal chemistry. One notable example is 1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one, which has been investigated as a metabolite of neuroleptic agents like Fluspirilene. It has a molecular formula of C13H17N3O and a melting point of 188-191 °C.
Synthesis
The original synthesis was first disclosed by Paul Janssen,[1] and was covered by Daniel Lednicer in one of his books.[2]
A recent synthesis of spirodecanone is disclosed:[3][4]

The Strecker-like condensation between N-benzyl-4-piperidone [3612-20-2] (1), aniline and TMSCN [7677-24-9], gives 4-anilino-1-benzylpiperidine-4-carbonitrile [968-86-5] (2). Acid catalyzed partial hydrolysis of the nitrile to the amide afforded 4-anilino-1-benzylpiperidine-4-carboxamide [1096-03-3] (3). Reaction with DMF-DMA forms the spiroimidazolidone ring giving 8-benzyl-1-phenyl-1,3,8-triazaspiro[4.5]dec-2-en-4-one [974-42-5] (4). The imine bond is reduced with sodium borohydride giving 8-benzyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one [974-41-4] (5). Catalytic hydrogenation then removes the benzyl group (6).
It is noteworthy to mention that intermediate 4 finds dual use in the synthesis of some highly potent fentanyl analogs.[5]
Applications
Listed in alphabetical order:
- DiPOA
- Fluspiperone is similar but with additional para-fluoro.
- Fluspirilene
- L008716
- Phencyclidine analog[6]
- R-5260 [1109-69-9] (normethadone analog)
- R 6890 (spirochlorphine)
- RP-23618 [207991-30-8]
- Spiramide
- Spiroxatrine contains a Benzodioxan sidechain.
- Spirilene [357-66-4]
- Spiperone
- Ro64-6198 & Ro65-6570 (NOP receptor agonist).
- BRN 4620880 [99756-32-8]
- 8-(5,8-Dichloro-1,2,3,4-tetrahydro-2-naphthyl)-1-phenyl-1,3,8-triaza-spiro(4.5)decan-4-one.[7]
References
- ^ Janssen Paul Adriaan Jan, US3155669, US3155670, US3161644 & US3238216 (1964, 1964, 1964 & 1966 all to Research Laboratorium C Janssen NV).
- ^ Strategies for Organic Drug Synthesis and Design, second edition, by Daniel Lednicer (page 335).
- ^ Morciano, G.; Preti, D.; Pedriali, G.; Aquila, G.; Missiroli, S.; Fantinati, A.; Caroccia, N.; Pacifico, S.; Bonora, M.; Talarico, A.; Morganti, C.; Rizzo, P.; Ferrari, R.; Wieckowski, M. R.; Campo, G.; Giorgi, C.; Trapella, C.; Pinton, P. (23 August 2018). "Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F 1 /F O -Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction". Journal of Medicinal Chemistry. 61 (16): 7131–7143. doi:10.1021/acs.jmedchem.8b00278. hdl:11392/2397146. PMID 30060655.
- ^ 盛春泉, et al. CN113480536 (2021 to Second Military Medical University SMMU).
- ^ Walz, A. J.; Hsu, F.-L. (January 2014). "Synthesis of 4-anilinopiperidine methyl esters, intermediates in the production of carfentanil, sufentanil, and remifentanil". Tetrahedron Letters. 55 (2): 501–502. doi:10.1016/j.tetlet.2013.11.058.
- ^ Alberati, D.; Hainzl, D.; Jolidon, S.; Kurt, A.; Pinard, E.; Thomas, A. W.; Zimmerli, D. (August 2006). "4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters". Bioorganic & Medicinal Chemistry Letters. 16 (16): 4321–4325. doi:10.1016/j.bmcl.2006.05.063. PMID 16762550.
- ^ Röver, S.; Adam, G.; Cesura, A. M.; Galley, G.; Jenck, F.; Monsma, F. J.; Wichmann, J.; Dautzenberg, F. M. (6 April 2000). "High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor". Journal of Medicinal Chemistry. 43 (7): 1329–1338. doi:10.1021/jm991129q. PMID 10753470.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
